Evaluating the influence of selection markers on obtaining selected pools and stable cell lines in human cells

被引:39
作者
Lanza, Amanda M. [1 ]
Kim, Do Soon [1 ]
Alper, Hal S. [1 ,2 ]
机构
[1] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA
[2] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA
基金
美国国家科学基金会;
关键词
Hygromycin B; Mammalian selection marker; Neomycin; Puromycin; Zeocin; MAMMALIAN-CELLS; CHO CELLS; RECOMBINANT PROTEIN; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; RESISTANCE; DNA; INTEGRATION; CULTURE; VECTOR;
D O I
10.1002/biot.201200364
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Selection markers are common genetic elements used in recombinant cell line development. While several selection systems exist for use in mammalian cell lines, no previous study has comprehensively evaluated their performance in the isolation of recombinant populations and cell lines. Here we examine four antibiotics, hygromycin B, neomycin, puromycin, and Zeocin, and their corresponding selector genes, using a green fluorescent protein (GFP) as a reporter in two model cell lines, HT1080 and HEK293. We identify Zeocin as the best selection agent for cell line development in human cells. In comparison to the other selection systems, Zeocin is able to identify populations with higher fluorescence levels, which in turn leads to the isolation of better clonal populations and less false positives. Furthermore, Zeocin-resistant populations exhibit better transgene stability in the absence of selection pressure compared to other selection agents. All isolated Zeocin-resistant clones, regardless of cell type, exhibited GFP expression. By comparison, only 79% of hygromycin B-resistant, 47% of neomycin-resistant, and 14% of puromycin-resistant clones expressed GFP. Based on these results, we rank Zeocin > hygromycin B approximate to puromycin > neomycin for cell line development in human cells. Furthermore, this study demonstrates that selection marker choice does indeed impact cell line development.
引用
收藏
页码:811 / +
页数:2
相关论文
共 45 条
[21]   Emerging synthetic biology tools for engineering mammalian cell systems and expediting cell line development [J].
Lanza, Amanda M. ;
Cheng, Joseph K. ;
Alper, Hal S. .
CURRENT OPINION IN CHEMICAL ENGINEERING, 2012, 1 (04) :403-410
[22]   Using the Cre/lox system for targeted integration into the human genome: loxFAS-loxP pairing and delayed introduction of Cre DNA improve gene swapping efficiency [J].
Lanza, Amanda M. ;
Dyess, Timothy J. ;
Alper, Hal S. .
BIOTECHNOLOGY JOURNAL, 2012, 7 (07) :898-908
[23]   Cell culture processes for monoclonal antibody production [J].
Li, Feng ;
Vijayasankaran, Natarajan ;
Shen, Amy ;
Kiss, Robert ;
Amanullah, Ashraf .
MABS, 2010, 2 (05) :466-479
[24]   Selectable marker genes in transgenic plants: applications, alternatives and biosafety [J].
Miki, B ;
McHugh, S .
JOURNAL OF BIOTECHNOLOGY, 2004, 107 (03) :193-232
[25]   PHLEOMYCIN RESISTANCE AS A DOMINANT SELECTABLE MARKER IN CHO CELLS [J].
MULSANT, P ;
GATIGNOL, A ;
DALENS, M ;
TIRABY, G .
SOMATIC CELL AND MOLECULAR GENETICS, 1988, 14 (03) :243-252
[26]   Cell Engineering and Cultivation of Chinese Hamster Ovary (CHO) Cells [J].
Omasa, Takeshi ;
Onitsuka, Masayoshi ;
Kim, Wook-Dong .
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2010, 11 (03) :233-240
[27]   EFFECTS OF METHOTREXATE ON TRANSFECTED DNA STABILITY IN MAMMALIAN-CELLS [J].
PALLAVICINI, MG ;
DETERESA, PS ;
ROSETTE, C ;
GRAY, JW ;
WURM, FM .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (01) :401-404
[28]   The vesicle-trafficking protein munc18b increases the secretory capacity of mammalian cells [J].
Peng, Ren-Wang ;
Guetg, Claudio ;
Tigges, Marcel ;
Fussenegger, Martin .
METABOLIC ENGINEERING, 2010, 12 (01) :18-25
[29]   INHIBITORS OF RIBOSOME FUNCTIONS [J].
PESTKA, S .
ANNUAL REVIEW OF MICROBIOLOGY, 1971, 25 :487-+
[30]   Strategies for Selecting Recombinant CHO Cell Lines for cGMP Manufacturing: Improving the Efficiency of Cell Line Generation [J].
Porter, Alison J. ;
Racher, Andrew J. ;
Preziosi, Richard ;
Dickson, Alan J. .
BIOTECHNOLOGY PROGRESS, 2010, 26 (05) :1455-1464